Especially the physiologic, the biologic, pathways of obesity, trying to really connect the science with modern understanding of what it actually is and what it isn't. Obesity still carries unique challenges compared to other chronic conditions
This dual action not only encourages insulin release but also reduces appetite, making it a strong ally in managing body mass
Unlike older medications, tirzepatide activates both GLP-1 and GIP receptors, offering a dual-action approach to curbing appetite and enhancing insulin sensitivity
New patients should avoid multi-month prepayments until they have confirmed their starting dose works for them
Tirzepatide side effects and semaglutide side effects include: Gastrointestinal issues
Significant weight loss typically occurs over several months, depending on adherence to the treatment plan